The changing face of esophageal cancer

Cancers

Volumn 2, Issue 3, 2010, Pages 1379-1404

  Melhado, Rachel E ^a   Alderson, Derek ^a   Tucker, Olga ^a  

^a QUEEN ELIZABETH HOSPITAL   (United Kingdom)

Author keywords

Epidemiology; Esophageal adenocarcinoma; Esophageal carcinoma; Esophageal squamous cell carcinoma; Risk factors

Indexed keywords

OPIATE; POLYCYCLIC AROMATIC HYDROCARBON;

ALCOHOL CONSUMPTION; BARRETT ESOPHAGUS; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER MORTALITY; DIETARY INTAKE; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGITIS; GASTROESOPHAGEAL REFLUX; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GEOGRAPHIC DISTRIBUTION; HELICOBACTER INFECTION; HUMAN; OBESITY; RACE DIFFERENCE; REVIEW; RISK FACTOR; SEX DIFFERENCE; SMOKING; SYSTEMATIC REVIEW;

EID: 79952266771     PISSN: None     EISSN: 20726694     Source Type: Journal    
DOI: 10.3390/cancers2031379     Document Type: Review

References (121)

1. Ferlay, J.; Bray, F.; Pisani, P.; Parkin, D.M. GLOBOCAN 2002: Cancer Incidence, Mortality and Prevalence Worldwide; IARC Press: Lyon, France, 2004.
2. Kmet, J.; Mahboubi, E. Esophageal cancer in the Caspian littoral of Iran: initial studies. Science 1972, 175, 846-853.
3. Khuroo, M.S.; Zargar, S.A.; Mahajan, R.; Banday, M.A. High incidence of esophageal and gastric cancer in Kashmir in a population with special personal and dietary habits. Gut 1992, 33, 11-15.
4. Zaridze, D.G.; Basieva, T.; Kabulov, M.; Day, N.E.; Duffy, S.W. Esophageal cancer in the Republic of Karakalpakstan. Int. J. Epidemiol. 1992, 21, 643-648.
5. Day, N.E. Some aspects of the epidemiology of esophageal cancer. Cancer Res. 1975, 35, 3304-3307.
6. Vizcaino, A.P.; Moreno, V.; Lambert, R.; Parkin, D.M. Time trends incidence of both major histologic types of esophageal carcinomas in selected countries, 1973-1995. Int. J. Cancer 2002, 99, 860-868.
7. Curado. M.P., Edwards, B., Shin, H.R., Storm, H., Ferlay, J., Heanue, M., Boyle, P., Eds.; In Cancer Incidence in Five Continents, IARC Sci. Publ. No. 160; IARC: Lyon, France, 2007.
8. Horner, M.J., Ries, L., Krapcho, M., Neyman, N., Aminou, R., Howlader, N., Altekruse, S.F., Feuer, E.J., Huang, L., Mariotto, A., Miller, B.A., Lewis, D.R., Eisner, M.P., Stinchcomb, D.G., Edwards, B.K., Eds.; SEER Cancer Statistics Review, 1975-2006; National Cancer Institute: Bethesda, MD, USA, 2009.
9. Zambon, P.; Talamini, R.; Vecchia, C.L.; Maso, L.D.; Negri, E.; Tognazzo, S.; Simonato, L.; Franceschi, S. Smoking, type of alcoholic beverage and squamous-cell esophageal cancer in northern Italy. Int. J. Cancer 2000, 86, 144-149.
10. Negri, E.; La Vecchia, C.; Franceschi, S.; Decarli, A.; Bruzzi, P. Attributable risks for esophageal cancer in northern Italy. Eur. J. Cancer 1992, 28A, 1167-1171.
11. Cook, M.B.; Chow, W.H.; Devesa, S.S. Esophageal cancer incidence in the United States by race, sex, and histologic type, 1977-2005. Br. J. Cancer 2009, 101, 855-859.
12. Islami, F.; Kamangar, F.; Aghcheli, K.; Fahimi, S.; Semnani, S.; Taghavi, N.; Marjani, H.A.; Merat, S.; Nasseri-Moghaddam, S.; Pourshams, A.; et al. Epidemiologic features of upper gastrointestinal tract cancers in Northeastern Iran. Br. J. Cancer 2004, 90, 1402-1406.
13. Mahboubi, E.; Kmet, J.; Cook, P.J.; Day, N.E.; Ghadirian, P.; Salmasizadeh, S. Esophageal cancer studies in the Caspian Littoral of Iran: the Caspian cancer registry. Br. J. Cancer 1973, 28, 197-214.
14. Gholipour, C.; Shalchi, R.A.; Abbasi, M. A histopathological study of esophageal cancer on the western side of the Caspian littoral from 1994 to 2003. Dis. Esophagus 2008, 21, 322-327.
15. Pourshams, A.; Khademi, H.; Malekshah, A.F.; Islami, F.; Nouraei, M.; Sadjadi, A.R.; Jafari, E.; Rakhshani, N.; Salahi, R.; Semnani, S.; et al. Cohort Profile: The Golestan Cohort Study-a prospective study of esophageal cancer in northern Iran. Int. J. Epidemiol. 2009, 39, 52-59.
16. Semnani, S.; Sadjadi, A.; Fahimi, S.; Nouraie, M.; Naeimi, M.; Kabir, J.; Fakheri, H.; Saadatnia, H.; Ghavamnasiri, M.R.; Malekzadeh, R. Declining incidence of esophageal cancer in the Turkmen Plain, eastern part of the Caspian Littoral of Iran: a retrospective cancer surveillance. Cancer Detect. Prev. 2006, 30, 14-19.
17. Lambert, R.; Hainaut, P. Epidemiology of esophagogastric cancer. Best Pract. Res. Clin. Gastroenterol. 2007, 21, 921-945.
18. He, Y.T.; Hou, J.; Qiao, C.Y.; Chen, Z.F.; Song, G.H.; Li, S.S.; Meng, F.S.; Jin, H.X.; Chen, C. An analysis of esophageal cancer incidence in Cixian county from 1974 to 1996. World J. Gastroenterol. 2003, 9, 209-213.
19. Ke, L. Mortality and incidence trends from esophagus cancer in selected geographic areas of China circa 1970-90. Int. J. Cancer 2002, 102, 271-274.
20. Rose, E.F.; McGlashan, N.D. The spatial distribution of esophageal carcinoma in the Transkei, South Africa. Br. J. Cancer 1975, 31, 197-206.
21. Zheng, T.; Mayne, S.T.; Holford, T.R.; Boyle, P.; Liu, W.; Chen, Y.; Mador, M.; Flannery, J. Time trend and age-period-cohort effects on incidence of esophageal cancer in Connecticut, 1935-89. Cancer Causes Contr. 1992, 3, 481-492.
22. Brown, L.M.; Devesa, S.S.; Chow, W.H. Incidence of adenocarcinoma of the esophagus among white Americans by sex, stage, and age. J. Natl. Cancer Inst. 2008, 100, 1184-1187.
23. Crane, S.J.; Richard Locke, G., 3rd; Harmsen, W.S.; Diehl, N.N.; Zinsmeister, A.R.; Joseph Melton, L., 3rd; Romero, Y.; Talley, N.J. The changing incidence of esophageal and gastric adenocarcinoma by anatomic sub-site. Aliment. Pharmacol. Ther. 2007, 25, 447-453.
24. Devesa, S.S.; Blot, W.J.; Fraumeni, J.F., Jr. Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer 1998, 83, 2049-2053.
25. Gajperia, C.; Barbiere, J.M.; Greenberg, D.; Wright, K.; Lyratzopoulos, G. Recent incidence trends and sociodemographic features of esophageal and gastric cancer types in an English region. Aliment. Pharmacol. Ther. 2009, 30, 873-880.
26. El-Serag, H.B.; Mason, A.C.; Petersen, N.; Key, C.R. Epidemiological differences between adenocarcinoma of the esophagus and adenocarcinoma of the gastric cardia in the USA. Gut 2002, 50, 368-372.
27. Sihvo, E.I.; Salminen, J.T.; Ramo, O.J.; Salo, J.A. The epidemiology of esophageal adenocarcinoma: has the cancer of gastric cardia an influence on the rising incidence of esophageal adenocarcinoma? Scand. J. Gastroenterol. 2000, 35, 1082-1086.
28. Hansen, S.; Wiig, J.N.; Giercksky, K.E.; Tretli, S. Esophageal and gastric carcinoma in Norway 1958-1992: Incidence time trend variability according to morphological subtypes and organ subsites. Int. J. Cancer 1997, 71, 340-344.
29. Falk, J.; Carstens, H.; Lundell, L.; Albertsson, M. Incidence of carcinoma of the esophagus and gastric cardia. Changes over time and geographical differences. Acta Oncol. 2007, 46, 1070-1074.
30. Armstrong, R.W.; Borman, B. Trends in Incidence Rates of Adenocarcinoma of the Esophagus and Gastric Cardia in New Zealand, 1978-1992. Int. J. Epidemiol. 1996, 25, 941-947.
31. Lepage, C.; Rachet, B.; Jooste, V.; Faivre, J.; Coleman, M.P. Continuing rapid increase in esophageal adenocarcinoma in England and Wales. Am. J. Gastroenterol. 2008, 103, 2694-2699.
32. Macfarlane, G.J.; Boyle, P. The epidemiology of esophageal cancer in the UK and other European countries. J. R. Soc. Med. 1994, 87, 334-337.
33. Dolan, K.; Sutton, R.; Walker, S.J.; Morris, A.I.; Campbell, F.; Williams, E.M. New classification of esophageal and gastric carcinomas derived from changing patterns in epidemiology. Br. J. Cancer 1999, 80, 834-842.
34. Botterweck, A.A.; Schouten, L.J.; Volovics, A.; Dorant, E.; van den Brandt, P.A. Trends in incidence of adenocarcinoma of the esophagus and gastric cardia in ten European countries. Int. J. Epidemiol. 2000, 29, 645-654.
35. Hongo, M. Review article: Barrett's esophagus and carcinoma in Japan. Aliment. Pharmacol. Ther. 2004, 20, 50-54.
36. Cook-Mozaffari, P.J.; Azordegan, F.; Day, N.E.; Ressicaud, A.; Sabai, C.; Aramesh, B. Esophageal cancer studies in the Caspian Littoral of Iran: results of a case-control study. Br. J. Cancer 1979, 39, 293-309.
37. Brown, L.M.; Hoover, R.; Silverman, D.; Baris, D.; Hayes, R.; Swanson, G.M.; Schoenberg, J.; Greenberg, R.; Liff, J.; Schwartz, A.; et al. Excess incidence of squamous cell esophageal cancer among US Black men: role of social class and other risk factors. Am. J. Epidemiol. 2001, 153, 114-122.
38. Yang, C.X.; Wang, H.Y.; Wang, Z.M.; Du, H.Z.; Tao, D.M.; Mu, X.Y.; Chen, H.G.; Lei, Y.; Matsuo, K.; Tajima, K. Risk factors for esophageal cancer: a case-control study in South-western China. Asian Pac. J. Cancer Prev. 2005, 6, 48-53.
39. Launoy, G.; Milan, C.; Day, N.E.; Pienkowski, M.P.; Gignoux, M.; Faivre, J. Diet and squamous-cell cancer of the esophagus: a French multicentre case-control study. Int. J. Cancer 1998, 76, 7-12.
40. Hormozdiari, H.; Day, N.E.; Aramesh, B.; Mahboubi, E. Dietary factors and esophageal cancer in the Caspian Littoral of Iran. Cancer Res. 1975, 35, 3493-3498.
41. Guo, W.; Blot, W.J.; Li, J.Y.; Taylor, P.R.; Liu, B.Q.; Wang, W.; Wu, Y.P.; Zheng, W.; Dawsey, S.M.; Li, B.; et al. A nested case-control study of esophageal and stomach cancers in the Linxian nutrition intervention trial. Int. J. Epidemiol. 1994, 23, 444-450.
42. Abnet, C.C.; Lai, B.; Qiao, Y.L.; Vogt, S.; Luo, X.M.; Taylor, P.R.; Dong, Z.W.; Mark, S.D.; Dawsey, S.M. Zinc concentration in esophageal biopsy specimens measured by x-ray fluorescence and esophageal cancer risk. J. Natl. Cancer Inst. 2005, 97, 301-306.
43. Wei, W.Q.; Abnet, C.C.; Qiao, Y.L.; Dawsey, S.M.; Dong, Z.W.; Sun, X.D.; Fan, J.H.; Gunter, E.W.; Taylor, P.R.; Mark, S.D. Prospective study of serum selenium concentrations and esophageal and gastric cardia cancer, heart disease, stroke, and total death. Am. J. Clin. Nutr. 2004, 79, 80-85.
44. Mark, S.D.; Qiao, Y.L.; Dawsey, S.M.; Wu, Y.P.; Katki, H.; Gunter, E.W.; Fraumeni, J.F., Jr.; Blot, W.J.; Dong, Z.W.; Taylor, P.R. Prospective study of serum selenium levels and incident esophageal and gastric cancers. J. Natl. Cancer Inst. 2000, 92, 1753-1763.
45. Nouarie, M.; Pourshams, A.; Kamangar, F.; Sotoudeh, M.; Derakhshan, M.H.; Akbari, M.R.; Fakheri, H.; Zahedi, M.J.; Caldwell, K.; Abnet, C.C.; et al. Ecologic study of serum selenium and upper gastrointestinal cancers in Iran. World J. Gastroenterol. 2004, 10, 2544-2546.
46. Castellsague, X.; Munoz, N.; De Stefani, E.; Victora, C.G.; Castelletto, R.; Rolon, P.A. Influence of mate drinking, hot beverages and diet on esophageal cancer risk in South America. Int. J. Cancer 2000, 88, 658-664.
47. De Jong, U.W.; Breslow, N.; Hong, J.G.; Sridharan, M.; Shanmugaratnam, K. Aetiological factors in esophageal cancer in Singapore Chinese. Int. J. Cancer 1974, 13, 291-303.
48. Ghadirian, P. Thermal irritation and esophageal cancer in northern Iran. Cancer 1987, 60, 1909-1914.
49. Segi, M. Tea-gruel as a possible factor for cancer for the esophagus. Gann 1975, 66, 199-202.
50. Islami, F.; Pourshams, A.; Nasrollahzadeh, D.; Kamangar, F.; Fahimi, S.; Shakeri, R.; Abedi-Ardekani, B.; Merat, S.; Vahedi, H.; Semnani, S.; et al. Tea drinking habits and esophageal cancer in a high risk area in northern Iran: population based case-control study. BMJ 2009, 338, b929-b936.
51. Sewram, V.; De Stefani, E.; Brennan, P.; Boffetta, P. Mate consumption and the risk of squamous cell esophageal cancer in uruguay. Cancer Epidemiol. Biomarkers Prev. 2003, 12, 508-513.
52. Fagundes, R.B.; Abnet, C.C.; Strickland, P.T.; Kamangar, F.; Roth, M.J.; Taylor, P.R.; Dawsey, S.M. Higher urine 1-hydroxy pyrene glucuronide (1-OHPG) is associated with tobacco smoke exposure and drinking mate in healthy subjects from Rio Grande do Sul, Brazil. BMC Cancer 2006, 6, 139.
53. O'Neill, C.; Pan, Q.; Clarke, G.; Liu, F.; Hodges, G.; Ge, M.; Jordan, P.; Chang, U.; Newman, R.; Toulson, E. Silica fragments from millet bran in mucosa surrounding esophageal tumours in patients in northern China. Lancet 1982, 1, 1202-1206.
54. O'Neill, C.H.; Hodges, G.M.; Riddle, P.N.; Jordan, P.W.; Newman, R.H.; Flood, R.J.; Toulson, E.C. A fine fibrous silica contaminant of flour in the high esophageal cancer area of north-east Iran. Int. J. Cancer 1980, 26, 617-628.
55. Parry, D.W.; O'Neill, C.H.; Hodson, M.J. Opaline Silica Deposits in the Leaves of Bidens pilosa L. and their Possible Significance in Cancer. Ann. Bot. 1986, 58, 641-647.
56. Pan, G.; Takahashi, K.; Feng, Y.; Liu, L.; Liu, T.; Zhang, S.; Liu, N.; Okubo, T.; Goldsmith, D.F. Nested case-control study of esophageal cancer in relation to occupational exposure to silica and other dusts. Am. J. Ind. Med. 1999, 35, 272-280.
57. Brown, L.M.; Hoover, R.N.; Greenberg, R.S.; Schoenberg, J.B.; Schwartz, A.G.; Swanson, G.M.; Liff, J.M.; Silverman, D.T.; Hayes, R.B.; Pottern, L.M. Are racial differences in squamous cell esophageal cancer explained by alcohol and tobacco use? J. Natl. Cancer Inst. 1994, 86, 1340-1345.
58. Tran, G.D.; Sun, X.-D.; Abnet, C.C.; Fan, J.-H.; Dawsey, S.M.; Dong, Z.-W.; Mark, S.D.; Qiao, Y.-L.; Taylor, P.R. Prospective study of risk factors for esophageal and gastric cancers in the Linxian general population trial cohort in China. Int. J. Cancer 2005, 113, 456-463.
59. Pourshams, A.; Saadatian-Elahi, M.; Nouraie, M.; Malekshah, A.F.; Rakhshani, N.; Salahi, R.; Yoonessi, A.; Semnani, S.; Islami, F.; Sotoudeh, M.; et al. Golestan cohort study of esophageal cancer: feasibility and first results. Br. J. Cancer 2005, 92, 176-181.
60. Ghadirian, P.; Stein, G.F.; Gorodetzky, C.; Roberfroid, M.B.; Mahon, G.A.; Bartsch, H.; Day, N.E. Esophageal cancer studies in the Caspian littoral of Iran: some residual results, including opium use as a risk factor. Int. J. Cancer 1985, 35, 593-597.
61. Kamangar, F.; Malekzadeh, R.; Dawsey, S.M.; Saidi, F. Esophageal cancer in Northeastern Iran: a review. Arch. Iran Med. 2007, 10, 70-82.
62. Roth, M.J.; Guo-Qing, W.; Lewin, K.J.; Ning, L.; Dawsey, S.M.; Wesley, M.N.; Giffen, C.; Yong-Qiang, X.; Maher, M.M.; Taylor, P.R. Histopathologic changes seen in esophagectomy specimens from the high-risk region of Linxian, China: potential clues to an etiologic exposure? Hum. Pathol. 1998, 29, 1294-1298.
63. Kamangar, F.; Strickland, P.T.; Pourshams, A.; Malekzadeh, R.; Boffetta, P.; Roth, M.J.; Abnet, C.C.; Saadatian-Elahi, M.; Rakhshani, N.; Brennan, P.; et al. High exposure to polycyclic aromatic hydrocarbons may contribute to high risk of esophageal cancer in northeastern Iran. Anticancer Res. 2005, 25, 425-428.
64. Preussmann, R.; Habs, M.; Habs, H.; Stununeyer, D. Fluoro-substituted N-nitrosamines. 6. Cardnogenidty of N-nitroso-(2,2,2-trifluoroethyl)-ethylamine in rats. Carcinogenesis 1983, 4, 755-757.
65. Lin, K.; Shen, W.; Shen, Z.; Wu, Y.; Lu, S. Dietary exposure and urinary excretion of total N-nitroso compounds, nitrosamino acids and volatile nitrosamine in inhabitants of high- and low-risk areas for esophageal cancer in southern China. Int. J. Cancer 2002, 102, 207-211.
66. Jakszyn, P.; Gonzalez, C.A. Nitrosamine and related food intake and gastric and esophageal cancer risk: a systematic review of the epidemiological evidence. World J. Gastroenterol. 2006, 12, 4296-4303.
67. Munoz, N.; Crespi, M.; Grassi, A.; Qing, W.G.; Qiong, S.; Cai, L.Z. Precursor lesions of esophageal cancer in high-risk populations in Iran and China. Lancet 1982, 1, 876-879.
68. Crespi, M.; Munoz, N.; Grassi, A.; Aramesh, B.; Amiri, G.; Mojtabai, A.; Casale, V. Esophageal lesions in northern Iran: a premalignant condition? Lancet 1979, 2, 217-221.
69. Jaskiewicz, K.; Venter, F.S.; Marasas, W.F. Cytopathology of the esophagus in Transkei. J. Natl. Cancer Inst. 1987, 79, 961-967.
70. Wang, G.Q.; Abnet, C.C.; Shen, Q.; Lewin, K.J.; Sun, X.D.; Roth, M.J.; Qiao, Y.L.; Mark, S.D.; Dong, Z.W.; Taylor, P.R.; et al. Histological precursors of esophageal squamous cell carcinoma: results from a 13 year prospective follow up study in a high risk population. Gut 2005, 54, 187-192.
71. Labenz, J.; Jaspersen, D.; Kulig, M.; Leodolter, A.; Lind, T.; Meyer-Sabellek, W.; Stolte, M.; Vieth, M.; Willich, S.; Malfertheiner, P. Risk factors for erosive esophagitis: a multivariate analysis based on the ProGERD study initiative. Am. J. Gastroenterol. 2004, 99, 1652-1656.
72. Jacob, J.H.; Riviere, A.; Mandard, A.M.; Munoz, N.; Crespi, M.; Etienne, Y.; Castellsague, X.; Marnay, J.; Lebigot, G.; Qiu, S.L. Prevalence survey of precancerous lesions of the esophagus in a high-risk population for esophageal cancer in France. Eur. J. Cancer Prev. 1993, 2, 53-59.
73. Brucher, B.L.; Stein, H.J.; Bartels, H.; Feussner, H.; Siewert, J.R. Achalasia and esophageal cancer: incidence, prevalence, and prognosis. World J. Surg. 2001, 25, 745-749.
74. Zaninotto, G.; Rizzetto, C.; Zambon, P.; Guzzinati, S.; Finotti, E.; Costantini, M. Long-term outcome and risk of esophageal cancer after surgery for achalasia. Br. J. Surg. 2008, 95, 1488-1494.
75. Kim, Y.T.; Sung, S.W.; Kim, J.H. Is it necessary to resect the diseased esophagus in performing reconstruction for corrosive esophageal stricture? Eur. J. Cardiothorac. Surg. 2001, 20, 1-6.
76. Kochhar, R.; Sethy, P.K.; Kochhar, S.; Nagi, B.; Gupta, N.M. Corrosive induced carcinoma of esophagus: report of three patients and review of literature. J. Gastroenterol. Hepatol. 2006, 21, 777-780.
77. Appelqvist, P.; Salmo, M. Lye corrosion carcinoma of the esophagus: a review of 63 cases. Cancer 1980, 45, 2655-2658.
78. Akbari, M.R.; Malekzadeh, R.; Nasrollahzadeh, D.; Amanian, D.; Sun, P.; Islami, F.; Sotoudeh, M.; Semnani, S.; Boffeta, P.; Dawsey, S.M.; et al. Familial risks of esophageal cancer among the Turkmen population of the Caspian littoral of Iran. Int. J. Cancer 2006, 119, 1047-1051.
79. Chen, X.B.; Chen, G.L.; Liu, J.N.; Yang, J.Z.; Yu, D.K.; Lin, D.X.; Tan, W. [Genetic polymorphisms in STK15 and MMP-2 associated susceptibility to esophageal cancer in Mongolian population]. Zhonghua Yu Fang Yi Xue Za Zhi 2009, 43, 559-564.
80. Druesne-Pecollo, N.; Tehard, B.; Mallet, Y.; Gerber, M.; Norat, T.; Hercberg, S.; Latino-Martel, P. Alcohol and genetic polymorphisms: effect on risk of alcohol-related cancer. Lancet Oncol. 2009, 10, 173-180.
81. Lao-Sirieix, P.; Caldas, C.; Fitzgerald, R.C. Genetic predisposition to gastro-esophageal cancer. Curr. Opin. Genet. Dev. 2010, 20, 210-217.
82. Lewis, S.J.; Smith, G.D. Alcohol, ALDH2, and esophageal cancer: a meta-analysis which illustrates the potentials and limitations of a Mendelian randomization approach. Cancer Epidemiol. Biomarkers Prev. 2005, 14, 1967-1971.
83. Dong, L.M.; Potter, J.D.; White, E.; Ulrich, C.M.; Cardon, L.R.; Peters, U. Genetic susceptibility to cancer: the role of polymorphisms in candidate genes. JAMA 2008, 299, 2423-2436.
84. Li, H.; Borinskaya, S.; Yoshimura, K.; Kal'ina, N.; Marusin, A.; Stepanov, V.A.; Qin, Z.; Khaliq, S.; Lee, M.Y.; Yang, Y.; et al. Refined geographic distribution of the oriental ALDH2*504Lys (nee 487Lys) variant. Ann. Hum. Genet. 2009, 73, 335-345.
85. Cui, R.; Kamatani, Y.; Takahashi, A.; Usami, M.; Hosono, N.; Kawaguchi, T.; Tsunoda, T.; Kamatani, N.; Kubo, M.; Nakamura, Y.; et al. Functional variants in ADH1B and ALDH2 coupled with alcohol and smoking synergistically enhance esophageal cancer risk. Gastroenterology 2009, 137, 1768-1775.
86. Ma, W.J.; Lv, G.D.; Zheng, S.T.; Huang, C.G.; Liu, Q.; Wang, X.; Lin, R.Y.; Sheyhidin, I.; Lu, X.M. DNA polymorphism and risk of esophageal squamous cell carcinoma in a population of North Xinjiang, China. World J. Gastroenterol. 2010, 16, 641-647.
87. Zhuo, W.L.; Zhang, Y.S.; Wang, Y.; Zhuo, X.L.; Zhu, B.; Cai, L.; Chen, Z.T. Association studies of CYP1A1 and GSTM1 polymorphisms with esophageal cancer risk: evidence-based meta-analyses. Arch. Med. Res. 2009, 40, 169-179.
88. Esquela-Kerscher, A.; Slack, F.J. Oncomirs [mdash] microRNAs with a role in cancer. Nat. Rev. Cancer 2006, 6, 259-269.
89. Zhou, S.L.; Wang, L.D. Circulating microRNAs: novel biomarkers for esophageal cancer. World J. Gastroenterol. 2010, 16, 2348-2354.
90. Sugito, N.; Ishiguro, H.; Kuwabara, Y.; Kimura, M.; Mitsui, A.; Kurehara, H.; Ando, T.; Mori, R.; Takashima, N.; Ogawa, R.; et al. RNASEN regulates cell proliferation and affects survival in esophageal cancer patients. Clin. Cancer Res. 2006, 12, 7322-7328.
91. Gammon, M.; Schoenberg, J.; Ahsan, H.; Risch, H.; Vaughan, T.; Chow, W.; Rotterdam, H.; West, A.; Dubrow, R.; Stanford, J.; et al. Tobacco, alcohol, and socioeconomic status and adenocarcinomas of the esophagus and gastric cardia. J. Natl. Cancer Inst. 1997, 89, 1277-1284.
92. El-Serag, H.; Hill, C.; Jones, R. Systematic review: the epidemiology of gastro-esophageal reflux disease in primary care, using the UK General Practice Research Database. Aliment. Pharmacol. Ther. 2009, 29, 470-480.
93. Garcia Rodriguez, L.A.; Lagergren, J.; Lindblad, M. Gastric acid suppression and risk of esophageal and gastric adenocarcinoma: a nested case control study in the UK. Gut 2006, 55, 1538-1544.
94. Solaymani-Dodaran, M.; Logan, R.F.; West, J.; Card, T.; Coupland, C. Risk of esophageal cancer in Barrett's esophagus and gastro-esophageal reflux. Gut 2004, 53, 1070-1074.
95. Ruigomez, A.; Garcia Rodriguez, L.A.; Wallander, M.A.; Johansson, S.; Graffner, H.; Dent, J. Natural history of gastro-esophageal reflux disease diagnosed in general practice. Aliment. Pharmacol. Ther. 2004, 20, 751-760.
96. Brown, L.M.; Devesa, S.S. Epidemiologic trends in esophageal and gastric cancer in the United States. Surg. Oncol. Clin. N. Am. 2002, 11, 235-256.
97. Haggitt, R.C.; Tryzelaar, J.; Ellis, F.H.; Colcher, H. Adenocarcinoma complicating columnar epithelium-lined (Barrett's) esophagus. Am. J. Clin. Pathol. 1978, 70, 1-5.
98. Kim, R.; Weissfeld, J.L.; Reynolds, J.C.; Kuller, L.H. Etiology of Barrett's metaplasia and esophageal adenocarcinoma. Cancer Epidemiol. Biomarkers Prev. 1997, 6, 369-377.
99. Miwa, K.; Sahara, H.; Segawa, M.; Kinami, S.; Sato, T.; Miyazaki, I.; Hattori, T. Reflux of duodenal or gastro-duodenal contents induces esophageal carcinoma in rats. Int. J. Cancer 1996, 67, 269-274.
100. Chow, W.-H.; Blaser, M.J.; Blot, W.J.; Gammon, M.D.; Vaughan, T.L.; Risch, H.A.; Perez-Perez, G.I.; Schoenberg, J.B.; Stanford, J.L.; Rotterdam, H.; et al. An Inverse Relation between cagA+ Strains of Helicobacter pylori Infection and Risk of Esophageal and Gastric Cardia Adenocarcinoma. Cancer Res. 1998, 58, 588-590.
101. Ye, W.; Held, M.; Lagergren, J.; Engstrand, L.; Blot, W.J.; McLaughlin, J.K.; Nyren, O. Helicobacter pylori Infection and Gastric Atrophy: Risk of Adenocarcinoma and Squamous-Cell Carcinoma of the Esophagus and Adenocarcinoma of the Gastric Cardia. J. Natl. Cancer Inst. 2004, 96, 388-396.
102. Wu, A.H.; Crabtree, J.E.; Bernstein, L.; Hawtin, P.; Cockburn, M.; Tseng, C.-C.; Forman, D. Role of Helicobacter pylori CagA+ strains and risk of adenocarcinoma of the stomach and esophagus. Int. J. Cancer 2003, 103, 815-821.
103. El-Omar, E.M. The importance of interleukin 1beta in Helicobacter pylori associated disease. Gut 2001, 48, 743-747.
104. Shaheen, N.J.; Crosby, M.A.; Bozymski, E.M.; Sandler, R.S. Is there publication bias in the reporting of cancer risk in Barrett's esophagus? Gastroenterology 2000, 119, 333-338.
105. van der Burgh, A.; Dees, J.; Hop, W.C.; van Blankenstein, M. Esophageal cancer is an uncommon cause of death in patients with Barrett's esophagus. Gut 1996, 39, 5-8.
106. O'Connor, J.B.; Falk, G.W.; Richter, J.E. The incidence of adenocarcinoma and dysplasia in Barrett's esophagus: report on the Cleveland Clinic Barrett's Esophagus Registry. Am. J. Gastroenterol. 1999, 94, 2037-2042.
107. Armstrong, D. Should patients with Barrett's esophagus be kept under surveillance? The case for. Best Pract. Res. Clin. Gastroenterol. 2008, 22, 721-739.
108. Post, P.N.; Siersema, P.D.; Van Dekken, H. Rising incidence of clinically evident Barrett's esophagus in The Netherlands: a nation-wide registry of pathology reports. Scand. J. Gastroenterol. 2007, 42, 17-22.
109. Jeon, J.; Luebeck, E.G.; Moolgavkar, S.H. Age effects and temporal trends in adenocarcinoma of the esophagus and gastric cardia (United States). Cancer Causes Cont. 2006, 17, 971-981.
110. Kuczmarski, R.J.; Flegal, K.M.; Campbell, S.M.; Johnson, C.L. Increasing Prevalence of Overweight Among US Adults: The National Health and Nutrition Examination Surveys, 1960 to 1991. JAMA 1994, 272, 205-211.
111. Morris Brown, L.; Swanson, C.A.; Gridley, G.; Swanson, G.M.; Schoenberg, J.B.; Greenberg, R.S.; Silverman, D.T.; Pottern, L.M.; Hayes, R.B.; Schwartz, A.G.; et al. Adenocarcinoma of the Esophagus: Role of Obesity and Diet. J. Natl. Cancer Inst. 1995, 87, 104-109.
112. Vaughan, T.L.; Davis, S.; Kristal, A.; Thomas, D.B. Obesity, alcohol, and tobacco as risk factors for cancers of the esophagus and gastric cardia: adenocarcinoma versus squamous cell carcinoma. Cancer Epidemiol. Biomarkers Prev. 1995, 4, 85-92.
113. Lindblad, M.; Rodriguez, L.A.; Lagergren, J. Body mass, tobacco and alcohol and risk of esophageal, gastric cardia, and gastric non-cardia adenocarcinoma among men and women in a nested case-control study. Cancer Causes Cont. 2005, 16, 285-294.
114. Lagergren, J.; Ye, W.; Bergstrom, R.; Nyren, O. Utility of Endoscopic Screening for Upper Gastrointestinal Adenocarcinoma. JAMA 2000, 284, 961-962.
115. Cook, M.B.; Greenwood, D.C.; Hardie, L.J.; Wild, C.P.; Forman, D. A systematic review and meta-analysis of the risk of increasing adiposity on Barrett's esophagus. Am. J. Gastroenterol. 2008, 103, 292-300.
116. Rubenstein, J.H.; Kao, J.Y.; Madanick, R.D.; Zhang, M.; Wang, M.; Spacek, M.B.; Donovan, J.L.; Bright, S.D.; Shaheen, N.J. Association of adiponectin multimers with Barrett's esophagus. Gut 2009, 58, 1583-1589.
117. Vaughan, T.L.; Kristal, A.R.; Blount, P.L.; Levine, D.S.; Galipeau, P.C.; Prevo, L.J.; Sanchez, C.A.; Rabinovitch, P.S.; Reid, B.J. Nonsteroidal anti-inflammatory drug use, body mass index, and anthropometry in relation to genetic and flow cytometric abnormalities in Barrett's esophagus. Cancer Epidemiol. Biomarkers Prev. 2002, 11, 745-752.
118. Eng, C.; Spechler, S.J.; Ruben, R.; Li, F.P. Familial Barrett esophagus and adenocarcinoma of the gastroesophageal junction. Cancer Epidemiol. Biomarkers Prev. 1993, 2, 397-399.
119. Chak, A.; Ochs-Balcom, H.; Falk, G.; Grady, W.M.; Kinnard, M.; Willis, J.E.; Elston, R.; Eng, C. Familiality in Barrett's Esophagus, Adenocarcinoma of the Esophagus, and Adenocarcinoma of the Gastroesophageal Junction. Cancer Epidemiol. Biomarkers Prev. 2006, 15, 1668-1673.
120. Feber, A.; Xi, L.; Luketich, J.D.; Pennathur, A.; Landreneau, R.J.; Wu, M.; Swanson, S.J.; Godfrey, T.E.; Litle, V.R. MicroRNA expression profiles of esophageal cancer. J. Thorac. Cardiovasc. Surg. 2008, 135, 255-260; discussion 260.
121. Yang, H.; Gu, J.; Wang, K.K.; Zhang, W.; Xing, J.; Chen, Z.; Ajani, J.A.; Wu, X. MicroRNA expression signatures in Barrett's esophagus and esophageal adenocarcinoma. Clin. Cancer Res. 2009, 15, 5744-5752.